Home / Latest Science News -- ScienceDaily / Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia

Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia

New research shows why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and demonstrates a way to restore their effectiveness.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210927172917.htm
Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia Reviewed by cmakigo on September 28, 2021 Rating: 5

You May Also Like

No comments:

Post a Comment

Subscribe to: Post Comments ( Atom )
'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.